CorpHQ Maintained At 'Buy/4,' Target $0.085 Set By Investrend Research Analyst Shailesh Dhuri.

NEW YORK -- (Investrend Research Syndicate) Investrend Research analyst Shailesh Dhuri, MBA, has released a comprehensive Institutional update on CorpHQ (OTC: COHQ), maintaining its rating at "Buy / 4," and establishing a three year target valuation of $0.085.

The analyst stated:

CorpHQ has successfully built a strong and vibrant portfolio in line with its strategy of identifying and incubating potentially high growth companies.

The company reported an EPS of $0.007 for FY04. Thus, the stock is trading at a P/E multiple of 4x. The reported EPS of the company includes valuation gain income of $0.005 per share. On a conservative basis, even if we adjust the valuation gains in EPS, the adjusted EPS works out to $0.002, or a multiple of 15x.

The operating cash flow of the company was also positive in FY04. Our analysis shows that if the company is able to maintain the current performance, the FY06E EPS will be $0.02.

CorpHQ's portfolio is comprised of several promising companies, such as: My Personal Salon (18.42% stake), with revenues of $15,000 for 2004 and a net loss of ($20,281); Safeguard Technology International, Inc. (9%), with revenues of $274,910 for 2004 and a net loss of ($699,435); South Bay Financial Solutions, Inc. (40%), which is in its very early development stage; and The Giving Card, which has entered into a Worldwide Licensing Agreement with the Vatican.

The topline increased by 44% in the year ended 2004 mainly on the back of a profitable divestment (gain of $0.12/share) in STI. The gain on STI is an impressive 150% of its acquisition cost.

A strengthened balance sheet is a key driver for future growth, and success of business strategies that the company is vigorously following.

Enrollment in standards-based research is an important measure of a company's commitment to transparency and Good Governance. Investrend Research's program facilitates independent analysts to provide coverage for shareholders in companies that otherwise would have little or no analyst following. Investrend subscribes to the "Standards for Independent Research Providers" at http://www.firstresearchconsortium.com, and the research is enrolled for investor-monitoring by the Shareholders Research Alliance at http://www.shareholdersresearch.com Enrollment fees for Institutional coverage are $32,490, and the fees were paid by the company. Analysts are paid in advance of initial reports by Investrend Research to eliminate pecuniary interest, and neither the analyst nor employees of Investrend Research may own or trade stocks of companies under coverage.

Complete information is available at the company's InvestorPower page at http://www.investrend.com/company/list.asp?sPathParam=yes, and the full report is available at http://www.investrendresearch.com. Investors are advised to read disclosures carefully before trading in the equities of any enrolled company.

Anyone interested in receiving alerts regarding CorpHQ research should email [e-mail] with "COHQ" in the subject line.